Page last updated: 2024-10-31

mirtazapine and Myotonic Dystrophy

mirtazapine has been researched along with Myotonic Dystrophy in 1 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Myotonic Dystrophy: Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ramon-Duaso, C1
Rodríguez-Morató, J1
Selma-Soriano, E1
Fernández-Avilés, C1
Artero, R1
de la Torre, R1
Pozo, ÓJ1
Robledo, P1

Other Studies

1 other study available for mirtazapine and Myotonic Dystrophy

ArticleYear
Protective effects of mirtazapine in mice lacking the Mbnl2 gene in forebrain glutamatergic neurons: Relevance for myotonic dystrophy 1.
    Neuropharmacology, 2020, 06-15, Volume: 170

    Topics: Animals; Animals, Genetically Modified; Drosophila; Female; Glutamic Acid; Male; Mice; Mice, Inbred

2020